CME Group registers strong Q3 2022 revenue thanks to increase in trading volume
International derivatives marketplace CME Group Inc. (NASDAQ:CME) today reported its financial results for the third quarter of 2022.
The company reported revenue of $1.2 billion and operating income of $739 million for the third quarter of 2022. This compares to revenues of $1.1 billion and operating income of $614 million registered in the third quarter of 2021.
Net income for the third quarter of 2022 was $680 million and diluted earnings per share were $1.87. On an adjusted basis, net income was $719 million and diluted earnings per share were $1.98.
“Our strong Q3 financial performance was driven by a 26% increase in trading volume, generating double-digit growth in total revenue,” said CME Group Chairman and Chief Executive Officer Terry Duffy. “During the quarter, year-over-year volume rose in five of our six asset classes, led by interest rates, equity indexes and a near-record quarter for foreign exchange. Likewise, the demand for our products remains strong, with year-to-date volumes up 22%, as clients continue to manage risk amid global economic and geopolitical uncertainty.”
Third-quarter 2022 average daily volume (ADV) was 22.4 million contracts, including non-U.S. ADV of 6.1 million contracts, led by 41% growth in Asia, 31% in Latin America, and 14% in EMEA.
Clearing and transaction fees revenue for third-quarter 2022 totalled $1.0 billion. The total average rate per contract was $0.631. Market data revenue totalled $154 million for third-quarter 2022.
As of September 30, 2022, the company had approximately $2.2 billion in cash (including $100 million deposited with Fixed Income Clearing Corporation (FICC) and included in other current assets) and $3.4 billion of debt.
The company paid dividends during the third quarter of approximately $363 million. The company has returned over $18.8 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.